Ret protein expression in adrenal medullary hyperplasia and pheochromocytoma

Endocrine Pathology

Volumn 14, Issue 4, 2003, Pages 351-361

  Powers, James F ^a   Brachold, Jaime M ^a   Tischler, Arthur S ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Adrenal medulla; Hyperplasia; Pheochromocytoma; Ret

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN RET;

ADRENAL GLAND; ADRENAL HYPERPLASIA; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PHENOTYPIC PLASTICITY; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIPPLE SYNDROME; STAINING;

ADRENAL GLAND NEOPLASMS; ADRENAL MEDULLA; ADULT; FEMALE; GANGLIONEUROBLASTOMA; GANGLIONEUROMA; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; PHEOCHROMOCYTOMA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 3042827291     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:14:4:351     Document Type: Article

References (27)

1. Baloh RH, Enomoto H, Johnson EM, Jr, Milbrandt J. The GDNF family ligands and receptors-implications for neural development. Curr Opin Neurobiol 10:103-110, 2000.
2. Rossel M, Pasini A, Chappuis S, et al. Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations. Oncogene 14:265-275, 1997.
3. Nelkin BD. Genetic mechanisms in multiple endocrine neoplasia type 2. Austin, TX: R. G. Landes Co., 1996.
4. Takaya K, Yoshimasa T, Arai H, et al. The RET proto-oncogene in sporadic pheochromocytomas. Intern Med 35:449-452, 1996.
5. Takaya K, Yoshimasa T, Arai H, et al. Expression of the RET proto-oncogene in normal human tissues, pheochromocytomas, and other tumors of neural crest origin. J Mol Med 74:617-621, 1996.
6. Nakamura T, Ishizaka Y, Nagao M, Hara M, Ishikawa T. Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin. J Pathol 172:255-260, 1994.
7. Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M, Asai J. Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. Oncogene 10:191-198, 1995.
8. Powers JF, Schelling KH, Tischler AS. Chromaffin cell mitogenesis by neurturin and glial cell line-derived neurotrophic factor. Neuroscience 108:341-349, 2001.
9. Pachnis V, Mankoo B, Costantini F. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119:1005-1017, 1993.
10. Golden JP, DeMaro JA, Osborne PA, Milbrandt J, Johnson EM, Jr. Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse. Exp Neurol 158:504-528, 1999.
11. Lindahl M, Timmusk T, Rossi J, Saarma M, Airaksinen MS. Expression and alternative splicing of mouse Gfra4 suggest roles in endocrine cell development. Mol Cell Neurosci 15:522-533, 2000.
12. Powers JF, Schelling K, Brachold JM, et al. High-level expression of receptor tyrosine kinase ret and responsiveness to ret-activating ligands in pheochromocytoma cell lines from neurofibromatosis knockout mice. Mol Cell Neurosci 20:382-389, 2002.
13. Taylor CR, Shi SR, Chen C, Young L, Yang C, Cote RJ. Comparative study of antigen retrieval heating methods: microwave, microwave and pressure cooker, autoclave, and steamer. Biotech Histochem 71:263-270, 1996.
14. Shi SR, Cote C, Kalra KL, Taylor CR, Tandon AK. A technique for retrieving antigens in formalin-fixed, routinely acid- decalcified, celloidin-embedded human temporal bone sections for immunohistochemistry. J Histochem Cytochem 40:787-792, 1992.
15. Takahashi M, Asai N, Iwashita T, Isomura T, Miyazaki K, Matsuyama M. Characterization of the ret proto-oncogene products expressed in mouse L cells. Oncogene 8:2925-2929, 1993.
16. Santoro M, Melillo RM, Carlomagno F, Fusco A, Vecchio G. Molecular mechanisms of RET activation in human cancer. Ann NY Acad Sci 963:116-121, 2002.
17. Tischler AS, DeLellis RA. Tumors of thyroid follicular epithelium: where have we been and where are we going? Endocr Pathol 13:267-269, 2002.
18. Le Hir H, Charlet-Berguerand N, Gimenez-Roqueplo A, et al. Relative expression of the RET9 and RET51 isoforms in human pheochromocytomas. Oncology 58:311-318, 2000.
19. Michael GJ, Priestley JV. Expression of trkA and p75 nerve growth factor receptors in the adrenal gland. Neuroreport 7:1617-1622, 1996.
20. Powers JF, Shahsavari M, Tsokas P, Tischler AS. Nerve growth factor receptor signaling in proliferation of normal adult rat chromaffin cells. Cell Tissue Res 295:21-32, 1999.
21. Tsui-Pierchala BA, Milbrandt J, Johnson EM, Jr. NGF utilizes c-Ret via a novel GFL-independent, inter-RTK signaling mechanism to maintain the trophic status of mature sympathetic neurons. Neuron 33:261-273, 2002.
22. Ikuno N, Shimokawa I, Nakamura T, Ishizaka Y, Ikeda T. Ret-oncogene expression correlates with neuronal differentiation of neuroblastic tumors. Pathol Res Pract 191:92-99, 1995.
23. Wada M, Asai N, Tsuzuki T, et al. Detection of ret homodimers in MEN 2A-associated pheochromocytomas. Biochem Biophys Res Commun 218:606-609, 1996.
24. Tsui-Pierchala BA, Ahrens RC, Crowder RJ, Milbrandt J, Johnson EM, Jr. The long and short isoforms of ret function as independent signaling complexes. J Biol Chem 277:34618-34625, 2002.
25. Tischler AS, Dichter MA, Biales B, DeLellis RA, Wolfe H. Neural properties of cultured human endocrine tumor cells of proposed neural crest origin. Science 192:902-904, 1976.
26. Tischler AS, Dayal Y, Balogh K, Cohen RB, Connolly JL, Tallberg K. The distribution of immunoreactive chromogranins, S-100 protein, and vasoactive intestinal peptide in compound tumors of the adrenal medulla. Hum Pathol 18:909-917, 1987.
27. Brady S, Lechan RM, Schwaitzberg SD, Dayal Y, Ziar J, Tischler AS. Composite pheochromocytoma/ganglioneuroma of the adrenal gland associated with multiple endocrine neoplasia 2A: case report with immunohistochemical analysis. Am J Surg Pathol 21:102-108, 1997.